Volume 18, Number 9—September 2012
Letter
Severe Measles, Vitamin A Deficiency, and the Roma Community in Europe
Table
Participant | Age, y/ sex | Signs and symptoms | Defining characteristics | Vitamin A level, mg/L† | Outcome | No. days in hospital |
---|---|---|---|---|---|---|
Case-patient 1 | 21/M | Rash, meningo-encephalitis | Positive PCR results for pharyngeal and urinary samples | 0.31 | Recovered | 12 |
Case-patient 2 | 25/M | Rash, hepatitis, keratitis | Positive PCR result for pharyngeal and urinary samples | 0.20 | Recovered | 4 |
Case-patient 3 | 26/M | Rash | Positive PCR result for pharyngeal sample | 0.27 | Recovered | 2 |
Case-patient 4 | 22/M | Rash | Positive PCR result for urinary, nasal, and pharyngeal samples; Positive serologic test result | 0.27 | Recovered | 3 |
Case-patient 5 | 15/M | Rash | Positive PCR result for nasal sample | 0.16 | Recovered | 1 |
Case-patient 6 | 17/M | Rash, hepatitis, Koplik spots | Clinical signs | 0.34 | Recovered | 2 |
Control 1 | 34/F | None | NA | 0.46 | NA | NA |
Control 2 | 12/M | None | NA | 0.36 | NA | NA |
*Control participants did not have measles. NA, not applicable.
†Reference range 0.5–0.8 mg/L.
Page created: August 17, 2012
Page updated: August 17, 2012
Page reviewed: August 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.